Beyond our on-going work to raise awareness, our work on access to medication in 2019 has been marked by very important advocacy work, at both national and European levels. In Spain, our work focused, on one hand, on complaints to political parties in the context of the various elections held throughout the year. On the other hand, we made petitions for transparency regarding the criteria for drug pricing and approval by the Administration. Likewise, the presentation of the report “Public Interest in Biomedical Innovation” led to a new debate on how research is financed in Spain and how to create greater social impact with the current enormous public investment. As always, our work has been performed in tandem with the advocacy and awareness activities of the It´s Not Healthy campaign. The campaign extended the debate on access to medication on a regional and autonomous level, in collaboration with dozens of organizations.